- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
* Unique position in multi-billion global market for aesthetic orthodontic devices
* Sales and marketing to be expanded into all key markets worldwide
* Nanostart ownership increased to about 25 percent
Nanostart AG has increased its ownership share in Singapore-based BioMers Pte Ltd. The proceeds from this current round of financing are to be used to expand the company's global sales network, especially in Europe and the USA. In particular, the company plans to hire new staff as well as to invest in wide-ranging sales and marketing activities. A further investment objective is to automate the company's production, which takes place in its Singapore headquarters.
BioMers produces innovative polymer composite wires based on nanotechnology. Its first successful commercial application has been in orthodontic wires used for braces and retainers. Until now, these wires had to be made of metal in order to have the needed physical properties. With its revolutionary technology, BioMers is now the world's only company able to produce these from clear or colored translucent plastic and thus to make braces and retainers which are aesthetically pleasing. This breakthrough provides the company with a decisive competitive advantage, giving it the potential to fundamentally transform the global market for orthodontic devices. BioMers offers a complete set of products for aesthetic orthodontic treatment.
"BioMers has a truly unique product portfolio in the field of orthodontics which fits very well with the current market trend," remarked Andreas Kröll, managing director of Singapore-based Nanostart subsidiary Nanostart Asia Pte Ltd. "The global market for braces is becoming much more oriented toward aesthetics, and this market - as well as the return potential for investors - is enormous."
Nanostart holds its position in BioMers as lead investor through its Nanostart Singapore Early Stage Venture Fund. With this transaction, the fund's shareholding in BioMers rises from 16 to about 25 percent.
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the "Entry Standard" segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. For further information about the company, please visit www.nanostart.de.
BioMers Pte Ltd is a spin-off of the world-renowned National University of Singapore (NUS). Using the company’s proprietary technology, originally developed at NUS, extremely strong nanofiber-reinforced polymer composites can be produced for various biomedical applications. These first of these revolutionary innovations to be brought to market are the company’s aesthetic products for orthodontic applications, including translucent wires for braces and translucent retainers. Further information may be found at www.biomersbraces.com.
Dr. Hans Joachim Dürr
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
Copyright © NanostartIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Application of Egg White in Production of Nanoparticles April 6th, 2015
Sunblock poses potential hazard to sea life August 20th, 2014
Nanotechnology used in sunscreens: a Mexican achievement May 14th, 2014
Graphene reduces wear of alumina ceramic March 26th, 2015
'Additive manufacturing' could greatly improve diabetes management March 17th, 2015